Iclazepam
In this article we are going to delve deeper into Iclazepam and explore its different facets. Iclazepam is an exciting topic that has captured the attention of many people over the years. From its impact on society to its implications on everyday life, Iclazepam is a topic that continues to generate interest and debate. Throughout this article, we will take a closer look at Iclazepam and discuss its relevance in various contexts. Additionally, we will explore the latest research and discoveries related to Iclazepam, in order to shed light on this fascinating topic. Without a doubt, Iclazepam is a topic worthy of attention and reflection, and this article seeks to offer a broad and complete look at it. Get ready to enter the world of Iclazepam and discover everything it has to offer.
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H21ClN2O2 |
| Molar mass | 368.86 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Iclazepam (Clazepam) is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and is around the same potency as chlordiazepoxide.
Iclazepam is a derivative of nordazepam substituted with a cyclopropylmethoxyethyl group on the N1 nitrogen. Once in the body, iclazepam is quickly metabolised to nordazepam and its N-(2-hydroxyethyl) derivative, which are thought to be mainly responsible for its effects.
See also
References
- ^ Giudicelli JF, Berdeaux A, Idrissi N, Richer C (January 1978). "Clazepam: pharmacokinetics and effects on performance". British Journal of Clinical Pharmacology. 5 (1): 65–9. doi:10.1111/j.1365-2125.1978.tb01599.x. PMC 1429233. PMID 23135.
 | This sedative-related article is a stub. You can help Wikipedia by expanding it. |